Pfizer Booster for Younger Teens Gets Clearance From FDA (3)

Jan. 3, 2022, 6:21 PM

U.S. regulators cleared Pfizer Inc.’s Covid-19 booster shot for younger adolescents, widening access to additional doses as parents seek to protect their kids from the omicron wave and school officials try to keep classrooms open.

The Food and Drug Administration said on Monday that it had granted an emergency-use authorization for people ages 12 to 15 to receive a third dose of the messenger RNA vaccine, which Pfizer developed with BioNTech SE.

The agency also reduced the recommended interval between the second and third doses of the Pfizer vaccine for all ages to five months. The FDA still ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.